CYSRT1: A Protein Targeted for Various Diseases (G375791)

Target Name: CYSRT1

NCBI ID: G375791

CYSRT1

CYSRT1: A Protein Targeted for Various Diseases

CYSRT1, also known as C9orf169, is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical forces.

Recent studies have identified CYSRT1 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because CYSRT1 plays a role in the regulation of cell division and growth, which is crucial for the development and progression of these diseases.

One of the reasons why CYSRT1 has been identified as a potential drug target is its role in the regulation of cell division. CYSRT1 is a key regulator of the G1/S transition, which is the stage of cell division where the cell prepares for cell division. During the G1/S transition, CYSRT1 helps to ensure that the cell has enough copies of its genetic material to divide correctly.

CYSRT1 is also involved in the regulation of cell growth. It helps to control the size and shape of cells, which is important for their proper functioning. This is important because if cells grow too large or too small, they can become damaged or dysfunctional, leading to the development of diseases.

In addition to its role in cell division and growth, CYSRT1 is also involved in the regulation of cell signaling. It is a key regulator of the TGF-β signaling pathway, which is a important pathway that is involved in the regulation of cell growth, differentiation, and inflammation.

CYSRT1 has also been identified as a potential biomarker for several diseases. For example, it has been shown to be elevated in the blood of people with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that CYSRT1 may be a useful biomarker for these diseases.

In addition to its potential clinical applications, CYSRT1 has also generated a lot of interest among researchers because of its unique structure and biology. CYSRT1 is a transmembrane protein that spans the cell membrane and is involved in the regulation of a wide range of cellular processes. This makes it an unusual target for drugs because it is difficult to reach and because of its complex structure, it is hard to predict how a drug will interact with it.

Overall, CYSRT1 is a protein that has the potential to be a drug target for a wide range of diseases. Its role in the regulation of cell division, growth, and signaling makes it an attractive target for drugs that are designed to treat these diseases. Additionally, its potential use as a biomarker for neurodegenerative diseases makes it an important step in the development of new treatments for these conditions.

Protein Name: Cysteine Rich Tail 1

The "CYSRT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYSRT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets